Genertec Universal Medical Group Co (HKSE:02666) Net Income : HK$2,308 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Genertec Universal Medical Group Co Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Genertec Universal Medical Group Co's Net Income for the six months ended in Dec. 2023 was HK$1,066 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$2,308 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Genertec Universal Medical Group Co's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$0.51.

Genertec Universal Medical Group Co Net Income Historical Data

The historical data trend for Genertec Universal Medical Group Co's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genertec Universal Medical Group Co Net Income Chart

Genertec Universal Medical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income

Get a 7-Day Free Trial

1,767.42

2,071.11

2,384.93

2,188.56

2,308.24

Genertec Universal Medical Group Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income	Get a 7-Day Free Trial															1,055.70	1,318.95	932.04	1,242.50	1,065.74

Genertec Universal Medical Group Co Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Genertec Universal Medical Group Co's Net Income for the fiscal year that ended in Dec. 2023 is calculated as

	Net Income		(A: Dec. 2023 )
=	Pre-Tax Income	+	Tax Provision	+	Net Income (Discontinued Operations)	+	Others
=	3135.003	+	-729.705	+	0	+	-97.056
=	2,308

Genertec Universal Medical Group Co's Net Income for the quarter that ended in Dec. 2023 is calculated as

	Net Income		(Q: Dec. 2023 )
=	Pre-Tax Income	+	Tax Provision	+	Net Income (Discontinued Operations)	+	Others
=	1424.885	+	-325.102	+	0	+	-34.039
=	1,066

Net Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$2,308 Mil.

Genertec Universal Medical Group Co (HKSE:02666) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Genertec Universal Medical Group Co's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2023 is calculated as

Earnings per Share (Diluted) (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(1065.744	-	0)	/	2082.889
	=	0.51

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.

Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.

Genertec Universal Medical Group Co Net Income Related Terms

Thank you for viewing the detailed overview of Genertec Universal Medical Group Co's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Genertec Universal Medical Group Co (HKSE:02666) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Credit Services » Genertec Universal Medical Group Co Ltd (HKSE:02666) » Definitions » Net Income

Comparable Companies

Traded in Other Exchanges

5UM:Germany

Address

8-1 Chongwenmenwai Street, 4th, 5th and 13th Floor, West Wing of Hademen Plaza, Dongcheng District, Beijing, CHN

Website

https://www.umcare.cn

Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The Group has two business segments; The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services, and The hospital group business comprises medical services, hospital, and healthcare management, import and export trade, and domestic trade of medical-related goods and life cycle management of equipment assets. Geographically, it derives a majority of its revenue from Mainland China.

Executives

Citic Capital Holdings Limited	2201 Interest of corporation controlled by you
Tong Yong Ji Shu Ji Tuan Xiang Gang Guo Ji Zi Ben You Xian Gong Si	2101 Beneficial owner
Zhong Guo Tong Yong Ji Shu Ji Tuan Kong Gu You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you
Cp Management Holdings Limited	2201 Interest of corporation controlled by you
Trustar Capital Holdings Limited	2201 Interest of corporation controlled by you
Sounda Properties Limited	2201 Interest of corporation controlled by you
Chu Mang Yee	2201 Interest of corporation controlled by you
Meta Group Limited	2201 Interest of corporation controlled by you
Sounda Hopson Technology Holdings Limited	2201 Interest of corporation controlled by you
Sounda Hopson Technology Investment Limited	2201 Interest of corporation controlled by you
Zhang Yichen	2201 Interest of corporation controlled by you
Citic Capital Partners Limited	2201 Interest of corporation controlled by you

Genertec Universal Medical Group Co (HKSE:02666) Headlines

No Headlines